These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 37185961)

  • 81. Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (non-APL)).
    Küley-Bagheri Y; Kreuzer KA; Monsef I; Lübbert M; Skoetz N
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD011960. PubMed ID: 30080246
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Interventions to reduce Staphylococcus aureus in the management of eczema.
    George SM; Karanovic S; Harrison DA; Rani A; Birnie AJ; Bath-Hextall FJ; Ravenscroft JC; Williams HC
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684694
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Ocrelizumab for multiple sclerosis.
    Lin M; Zhang J; Zhang Y; Luo J; Shi S
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013247. PubMed ID: 35583174
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Enteral nutrition for maintenance of remission in Crohn's disease.
    Akobeng AK; Zhang D; Gordon M; MacDonald JK
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD005984. PubMed ID: 30098021
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Angiogenesis Inhibitors for the Treatment of Ovarian Cancer: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Wang H; Xu T; Zheng L; Li G
    Int J Gynecol Cancer; 2018 Jun; 28(5):903-914. PubMed ID: 29561301
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Anti-epidermal growth factor receptor therapy for glioblastoma in adults.
    Lee A; Arasaratnam M; Chan DLH; Khasraw M; Howell VM; Wheeler H
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013238. PubMed ID: 32395825
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Efficacy and safety of chemotherapy or tyrosine kinase inhibitors combined with bevacizumab versus chemotherapy or tyrosine kinase inhibitors alone in the treatment of non-small cell lung cancer: a systematic review and meta-analysis.
    Sun L; Ma JT; Zhang SL; Zou HW; Han CB
    Med Oncol; 2015 Feb; 32(2):473. PubMed ID: 25603953
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pharmacological agents for adults with acute respiratory distress syndrome.
    Lewis SR; Pritchard MW; Thomas CM; Smith AF
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD004477. PubMed ID: 31334568
    [TBL] [Abstract][Full Text] [Related]  

  • 89. PEG-asparaginase treatment regimens for acute lymphoblastic leukaemia in children: a network meta-analysis.
    Lynggaard LS; Rank CU; Als-Nielsen B; Hoejfeldt SG; Heyman M; Schmiegelow K; Albertsen BK
    Cochrane Database Syst Rev; 2023 May; 5(5):CD014570. PubMed ID: 37260073
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Pre-emptive and preventive NSAIDs for postoperative pain in adults undergoing all types of surgery.
    Doleman B; Leonardi-Bee J; Heinink TP; Boyd-Carson H; Carrick L; Mandalia R; Lund JN; Williams JP
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD012978. PubMed ID: 34125958
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Immunosuppressive treatment for proliferative lupus nephritis.
    Tunnicliffe DJ; Palmer SC; Henderson L; Masson P; Craig JC; Tong A; Singh-Grewal D; Flanc RS; Roberts MA; Webster AC; Strippoli GF
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD002922. PubMed ID: 29957821
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Chemotherapy for advanced gastric cancer.
    Wagner AD; Syn NL; Moehler M; Grothe W; Yong WP; Tai BC; Ho J; Unverzagt S
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD004064. PubMed ID: 28850174
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Intratympanic corticosteroids for sudden sensorineural hearing loss.
    Plontke SK; Meisner C; Agrawal S; Cayé-Thomasen P; Galbraith K; Mikulec AA; Parnes L; Premakumar Y; Reiber J; Schilder AG; Liebau A
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD008080. PubMed ID: 35867413
    [TBL] [Abstract][Full Text] [Related]  

  • 94. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
    Greenhalgh J; Boland A; Bates V; Vecchio F; Dundar Y; Chaplin M; Green JA
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010383. PubMed ID: 33734432
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The efficacy and toxicity of angiogenesis inhibitors for ovarian cancer: a meta-analysis of randomized controlled trials.
    Guo C; Yan C; Qu L; Du R; Lin J
    Arch Gynecol Obstet; 2021 Feb; 303(2):285-311. PubMed ID: 33222040
    [TBL] [Abstract][Full Text] [Related]  

  • 96. PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer.
    Taylor AM; Chan DLH; Tio M; Patil SM; Traina TA; Robson ME; Khasraw M
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011395. PubMed ID: 33886122
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Alemtuzumab for multiple sclerosis.
    Riera R; Torloni MR; Martimbianco ALC; Pacheco RL
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD011203. PubMed ID: 37272540
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines.
    de Baat EC; Mulder RL; Armenian S; Feijen EA; Grotenhuis H; Hudson MM; Mavinkurve-Groothuis AM; Kremer LC; van Dalen EC
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD014638. PubMed ID: 36162822
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Dose-escalated radiotherapy for clinically localized and locally advanced prostate cancer.
    Kim S; Kong JH; Lee Y; Lee JY; Kang TW; Kong TH; Kim MH; You SH
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD012817. PubMed ID: 36884035
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial.
    Kurtz JE; Pujade-Lauraine E; Oaknin A; Belin L; Leitner K; Cibula D; Denys H; Rosengarten O; Rodrigues M; de Gregorio N; Martinez García J; Petru E; Kocián R; Vergote I; Pautier P; Schmalfeldt B; Gaba L; Polterauer S; Mouret Reynier MA; Sehouli J; Churruca C; Selle F; Joly F; D'Hondt V; Bultot-Boissier É; Lebreton C; Lotz JP; Largillier R; Heudel PE; Heitz F;
    J Clin Oncol; 2023 Oct; 41(30):4768-4778. PubMed ID: 37643382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.